TY - JOUR
T1 - The role of nutritional supplement on post-stroke fatigue: a pilot randomized controlled trial
AU - Giovannini, Silvia
AU - Iacovelli, Chiara
AU - Loreti, Claudia
AU - Lama, Elisabetta
AU - Morciano, Nadia
AU - Frisullo, Giovanni
AU - Biscotti, Lorenzo
AU - Padua, Luca
AU - Castelli, Letizia
PY - 2024
Y1 - 2024
N2 - Objectives: Post-stroke fatigue (PSF) is an experience characterized by an early feeling of exhaustion with fatigue, a
lack of energy, and difficulty in exertion, both motor and cognitive. To counteract fatigue and limit its effects on
activities of daily living, the use of vitamins and minerals is known in addition to the pharmacological approach.
However, few studies have evaluated the effect of vitamin and mineral supplementation on fatigue management.
SiderAL Med is a food for special medical purposes with a complete formulation containing vitamins, sucrosomal
minerals, copper and algal calcium. The aim of the study is to evaluate whether nutritional supplementation with
SiderAL Med improves the symptom of fatigue and motor and cognitive function in stroke patients.
Design: This is a pilot, randomized study with a control group.
Setting: Post-Acute Rehabilitation Unit of the Fondazione Policlinico “A. Gemelli” IRCCS.
Participants: Twenty-four patients with stroke outcomes, admitted to rehabilitation, were recruited and randomized
into the experimental group (Sid-G) and the control group (CG).
Intervention: The Sid-G patients, in association with the pharmacological and rehabilitation therapy foreseen during
hospitalization, took SiderAL1 Med, one sachet per day for 8 weeks, while the CG patients underwent only the
pharmacological and rehabilitation therapy foreseen in the daily routine.
Measurements: All patients were assessed at baseline (T0), after 4 weeks (T1), after 8 weeks (T2) and after 12 weeks
(T3) for motor and cognitive fatigue, balance, walking, functional capacity, cognitive performance, autonomy,
quality of life and body composition.
Results: Both Sid-G and CG patients showed significant improvement on most rating scales between T0-T1-T2-T3 (p=0.0001). When comparing the two groups, a statistically significant difference emerged in favor of Sid-G with
regard to motor fatigue (p=0.007), cognitive fatigue (p=0.009) and total fatigue (p=0.034); balance (p<0.001), functional capacity (p<0.001); cognitive performance (p=0.004); bone mineral content (p=0.005), lean
mass (p=0.005), total mass (p<0.001) and percentage of fat mass (p=0.039).
Conclusion: Nutritional supplementation with SiderAL Med, in concert with intensive rehabilitation treatment,
appears to be effective in managing fatigue and improving motor and cognitive performance and body composition,
representing a valuable tool to associate with rehabilitation treatment in stroke patients.
AB - Objectives: Post-stroke fatigue (PSF) is an experience characterized by an early feeling of exhaustion with fatigue, a
lack of energy, and difficulty in exertion, both motor and cognitive. To counteract fatigue and limit its effects on
activities of daily living, the use of vitamins and minerals is known in addition to the pharmacological approach.
However, few studies have evaluated the effect of vitamin and mineral supplementation on fatigue management.
SiderAL Med is a food for special medical purposes with a complete formulation containing vitamins, sucrosomal
minerals, copper and algal calcium. The aim of the study is to evaluate whether nutritional supplementation with
SiderAL Med improves the symptom of fatigue and motor and cognitive function in stroke patients.
Design: This is a pilot, randomized study with a control group.
Setting: Post-Acute Rehabilitation Unit of the Fondazione Policlinico “A. Gemelli” IRCCS.
Participants: Twenty-four patients with stroke outcomes, admitted to rehabilitation, were recruited and randomized
into the experimental group (Sid-G) and the control group (CG).
Intervention: The Sid-G patients, in association with the pharmacological and rehabilitation therapy foreseen during
hospitalization, took SiderAL1 Med, one sachet per day for 8 weeks, while the CG patients underwent only the
pharmacological and rehabilitation therapy foreseen in the daily routine.
Measurements: All patients were assessed at baseline (T0), after 4 weeks (T1), after 8 weeks (T2) and after 12 weeks
(T3) for motor and cognitive fatigue, balance, walking, functional capacity, cognitive performance, autonomy,
quality of life and body composition.
Results: Both Sid-G and CG patients showed significant improvement on most rating scales between T0-T1-T2-T3 (p=0.0001). When comparing the two groups, a statistically significant difference emerged in favor of Sid-G with
regard to motor fatigue (p=0.007), cognitive fatigue (p=0.009) and total fatigue (p=0.034); balance (p<0.001), functional capacity (p<0.001); cognitive performance (p=0.004); bone mineral content (p=0.005), lean
mass (p=0.005), total mass (p<0.001) and percentage of fat mass (p=0.039).
Conclusion: Nutritional supplementation with SiderAL Med, in concert with intensive rehabilitation treatment,
appears to be effective in managing fatigue and improving motor and cognitive performance and body composition,
representing a valuable tool to associate with rehabilitation treatment in stroke patients.
KW - Elderly
KW - Fatigue
KW - Nutritional Supplement
KW - Rehabilitation
KW - Stroke
KW - Elderly
KW - Fatigue
KW - Nutritional Supplement
KW - Rehabilitation
KW - Stroke
UR - http://hdl.handle.net/10807/277936
U2 - 10.1016/j.jnha.2024.100256
DO - 10.1016/j.jnha.2024.100256
M3 - Article
SN - 1279-7707
VL - 28
SP - N/A-N/A
JO - THE JOURNAL OF NUTRITION, HEALTH & AGING
JF - THE JOURNAL OF NUTRITION, HEALTH & AGING
ER -